We are live on ! Find out more
ALT icon

Altimmune
ALT

143 hedge funds and large institutions have $389M invested in Altimmune in 2023 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 41 increasing their positions, 24 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

391% more capital invested

Capital invested by funds: $79.2M → $389M (+$310M)

124% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 25

71% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 24

66% more call options, than puts

Call options by funds: $32M | Put options by funds: $19.3M

28% more funds holding

Funds holding: 112 → 143 (+31)

6.79% more ownership

Funds ownership: 57.53% → 64.32% (+6.8%)

Holders
143
Holders Change
+31
Holders Change %
+27.68%
% of All Funds
2.08%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.06%
New
56
Increased
41
Reduced
24
Closed
25
Calls
$32M
Puts
$19.3M
Net Calls
+$12.8M
Net Calls Change
+$11.5M

Top Buyers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
+$17.4M
2
Morgan Stanley
Morgan Stanley
New York
+$6.67M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$5.2M
4
TIM
Timelo Investment Management
Ontario, Canada
+$3.25M
5
Invesco
Invesco
Georgia
+$2.98M

Top Sellers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
-$7.18M
2
Marshall Wace
Marshall Wace
United Kingdom
-$7.15M
3
APM
Avidity Partners Management
Texas
-$3.02M
4
AAP
Ardsley Advisory Partners
Connecticut
-$2.72M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$2.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
1
Ameriprise
Minnesota
$47.1M +$17.4M +4,172,791 +38,314%
BlackRock
2
BlackRock
New York
$45.5M +$1.08M +257,791 +7%
Vanguard Group
3
Vanguard Group
Pennsylvania
$40.2M +$951K +227,677 +7%
TCM
4
Tang Capital Management
California
$30.9M – – –
Morgan Stanley
5
Morgan Stanley
New York
$23.4M +$6.67M +1,597,744 +330%
N
6
Nuveen
North Carolina
$19.4M -$7.18M -1,719,462 -50%
Point72 Asset Management
7
Point72 Asset Management
Connecticut
$14M +$5.2M +1,246,500 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$13.4M +$585K +140,192 +13%
State Street
9
State Street
Massachusetts
$11.4M +$600K +143,665 +16%
TIM
10
Timelo Investment Management
Ontario, Canada
$9.1M +$3.25M +779,095 +2,597%
Invesco
11
Invesco
Georgia
$8.39M +$2.98M +713,152 +2,159%
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$8.25M +$2.59M +619,488 +545%
Jane Street
13
Jane Street
New York
$6.53M +$2.18M +521,495 +885%
Group One Trading
14
Group One Trading
Illinois
$6.16M +$1.59M +380,791 +228%
Goldman Sachs
15
Goldman Sachs
New York
$5.9M +$1.68M +401,767 +328%
Northern Trust
16
Northern Trust
Illinois
$5.33M +$97.8K +23,419 +5%
Jacobs Levy Equity Management
17
Jacobs Levy Equity Management
New Jersey
$4.86M +$1.81M +432,341 New
LIP
18
Lighthouse Investment Partners
Florida
$4.49M +$1.67M +399,357 New
AAP
19
Ardsley Advisory Partners
Connecticut
$3.82M -$2.72M -651,050 -66%
Ensign Peak Advisors
20
Ensign Peak Advisors
Utah
$3.68M – – –
FAM
21
Fred Alger Management
New York
$3.67M +$1.36M +326,658 New
KCM
22
Kennedy Capital Management
Missouri
$3.43M +$1.27M +304,650 New
BWCS
23
Beirne Wealth Consulting Services
Connecticut
$3.42M +$227K +54,380 +22%
D.E. Shaw & Co
24
D.E. Shaw & Co
New York
$3.26M -$1.84M -441,006 -60%
Dimensional Fund Advisors
25
Dimensional Fund Advisors
Texas
$2.94M +$302K +72,267 +38%
1
2 3 4 5

ALT Hedge Fund Activity: Q4 2023 in Review

143 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q4 2023, worth a combined $389M — up 391% from $79.2M a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new ALT positions and 25 closed out — a net gain of 31 holders — while 41 added to existing stakes and 24 trimmed.

The largest buyer was Ameriprise, adding an estimated $17.4M. The largest seller was Nuveen, cutting an estimated $7.18M.

  • 143 institutional investors held Altimmune (ALT) as of Q4 2023, up from 112 in Q3 2023.
  • Funds reported $389M of Altimmune stock for Q4 2023, up 391% quarter-over-quarter.
  • 56 funds opened new Altimmune positions in Q4 2023 and 25 closed out, a net change of +31 holders.
  • The largest Altimmune buyer in Q4 2023 was Ameriprise, an estimated $17.4M added.
  • The largest Altimmune seller in Q4 2023 was Nuveen, an estimated $7.18M sold.

Based on aggregated 13F filings for Q4 2023.